The drug, paxlovid, is to be used for the treatment of mild-to-moderate COVID-19 in people 12 and older and who are at high risk of ...

A look at the two known types of the omicron variant and what BA.2's spread could mean for the nation's health care system.

Despite an apparent preference among some in the general public for Pfizer, experts have emphasized that getting a booster jab as soon as eligible, no ...

Less than 4% of all residents have received their booster, with the rollout stymied by initial plans for an eight-month shot interval and a seeming ...

Some experts are optimistic that more treatment options, a high vaccination rate and and a so-far lower mortality rate could herald a transition from pandemic ...